Legal Strategy as Sophisticated as Your Innovation

We have handled cases throughout the United States, including the district courts known for deciding major patent cases, as well as the Federal Circuit. That trial court experience — from pre-litigation counseling through Markman hearings, dispositive motions, and appeals — shapes every opinion, strategy, and negotiation we deliver, even when a matter never reaches a courtroom.

We bring decades of experience with patent and trade secret litigation, particularly under the Hatch-Waxman Act, where we've represented both brand and generic pharmaceutical companies. That experience — and the litigation risk it lets us see clearly — shapes our strategy for every IP dispute on which we advise.

We represent both appellants and appellees in cases covering a wide range of industries and issues, and have won substantial victories in appeals and challenges at the Court of Appeals for the Federal Circuit.

Our clients rely on us to deliver scientifically sound legal opinions — novelty/patentability, noninfringement, freedom-to-operate — for products, devices, and compositions, notably in the life sciences and chemical fields, including oral dosage forms, parenteral dosage forms and topicals, biomedical devices and systems, and chemicals and their formulations.

We also advise on products designed to avoid infringement, and we bring decades of litigation experience to IP and related FDA issues affecting 505(b)(1), 505(b)(2), and ANDA applications — from pre-litigation counseling through trial and appeal when a dispute can't be resolved any other way.

IP portfolio development and management requires consistent review, investment and updating. We thoroughly analyze our client's existing IP portfolio to understand their technology, scope, strengths and limitations, then help guide the client to develop an IP portfolio that meets their business objectives.

Our attorneys are licensed to practice before the U.S. Patent and Trademark Office, and have decades of experience prosecuting patent applications through allowance.

We are highly experienced in managing all aspects of complex trade secret litigation, notably in the pharmaceutical, chemical and biotech fields, including preliminary injunction and appellate practice.

We also advise clients on how to protect, enforce and exploit their trade secrets and other confidential information, providing strategic advice on safeguards, confidentiality policies and restrictive covenants.

We have experience with post-grant proceedings, including inter partes review (IPR) proceedings before the Patent Trial and Appeals Board (PTAB). We also have successfully represented clients in IPRs alongside related litigation.

With our extensive litigation experience, we are well placed to advise clients on strategic considerations when initiating and coordinating such disputes.

We work with our clients to negotiate agreements for intellectual property, technology and related know-how. We also have extensive experience preparing associated agreements including consulting agreements, collaboration agreements, purchase agreements, MSAs, supply agreements, development agreements and non-disclosure agreements.

In conjunction with intellectual property licensing, we advise our clients on ways to optimize their patent position with an eye toward future litigation and ensuring market exclusivity.

Our trademark and trade dress practice protects brand identity at every stage, while our copyright practice secures and enforces rights — through litigation including the DMCA — for creators and rights holders in film, manuscripts, and music.